![The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology](https://bjcardio.co.uk/files/uploads/2008/09/2-table-1.png)
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Information Theory–Based Surrogate Marker Evaluation from Several Randomized Clinical Trials with Binary Endpoints, Using SAS: Journal of Biopharmaceutical Statistics: Vol 18, No 2
![Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11357-022-00671-8/MediaObjects/11357_2022_671_Fig1_HTML.png)
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | SpringerLink
![PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855 PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855](https://image.slideserve.com/533855/surrogate-markers-and-its-role-in-the-drug-development-process-l.jpg)
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
![Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4f50ecfa-35e2-44b0-b777-cd31c8b5ed1c/sim5672-fig-0001-m.jpg)
Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library
![Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books](https://m.media-amazon.com/images/I/71D3QcR0ZUS._AC_UF1000,1000_QL80_.jpg)
Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books
![2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram 2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram](https://www.researchgate.net/publication/40798768/figure/fig7/AS:408360974340102@1474372251459/Relationship-between-a-surrogate-marker-and-true-outcome-adjusted-for-this-thesis-28.png)
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
Tympanic membrane pressure (TMP) as a surrogate marker of intracranial... | Download Scientific Diagram
![Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer](https://www.mdpi.com/cancers/cancers-13-03020/article_deploy/html/images/cancers-13-03020-g001.png)
Cancers | Free Full-Text | Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
![Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013 Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013](https://journals.sagepub.com/cms/10.1177/1740774513499652/asset/images/large/10.1177_1740774513499652-fig1.jpeg)
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013
![Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM](https://worldlinkmedical-uploads.azureedge.net/worldlinkmedical/2021/08/HbA1c-Test-Resized.png)
Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM
![Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01234-5/MediaObjects/12933_2021_1234_Fig1_HTML.png)